Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2001-04-27
2009-10-20
Mondesi, Robert B (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S184100, C424S093450
Reexamination Certificate
active
07604809
ABSTRACT:
The invention concerns the use ofLactobacillus caseiin a composition for oral administration to enhance immunity specific to pathogenic micro-organisms. Said composition can in particular be a food or a food supplement.
REFERENCES:
patent: 6329002 (2001-12-01), Kim et al.
patent: 6572854 (2003-06-01), De Simone
patent: 6699517 (2004-03-01), Boufassa et al.
patent: 96 20607 (1996-07-01), None
patent: 99 10476 (1999-03-01), None
Guerin-Danan, C. et al, Milk fermented with yogurt cultures and Lactobacillus casei compared with yogurt and gelled milk: influence on intestinal microflora in healthy infants , The American Journal of Clinical Nutrition, 1998, 67 (1) 111-117.
Spencer, J., Probiotics: Potential for reducing the salmonella and campylobacter carrier state in poultry—Part I Salmonella, Confernece: Animal feed biotechnology research and scientific regulation international roundtable, 1992, 97-102.
Perdigon, G. et al, Symposium: Probiotic bacteria for humans: clinical systems for evaluation of effectiveness, Journal of Dairy Science, 78: 1597-1606.
Guerin-Danan, C. et al., (The American Journal of Clinical Nutrition, 1998, 67 (1) 111-117).
(Viral Respiratory Infections, http://web.uct.ac.za/depts/mmi/jmoodie/vires2.html, pp. 1-8).
eMedicine Consumer Health (www.emedicinehealth.com/fulltext/15361.htm, pp. 1-5).
Yahui et al (Immunomodulatory function of lactic acid bacteria, Antonie van Leeuwenhoek, 1999; 76: 383-89).
Actimel™ and DanActive™ (www.actimel.com, p. 1 of 2).
(Wipe and Wash: Outwitting Germs in Child Care, Wisconsin Child Care limprovement Project, pp. 1-5).
Actimel: a hard act to follow (www.new-nutrition.com
ewspage/May0223a.htm.
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4).
Dermer (Bio/Technology, 1994, Vol. 12 p. 320).
Susana Alvarez et al., “Specific Immunity Induction at the Mucosal Level by Viable Lactobacillus Casei: A Perspective for Oral Vaccine Development”, Food and Agricultural Immunology, (1998) 10, pp. 79-87.
Gabriela Perdigon et al., “The Oral Administration of Lactic Acid Bacteria Increase the Mucosal Intestinal Immunity in Response to Enteropathogens”, Journal of Food Protection, vol. 53, No. 5, pp. 404-410, Jun. 12, 1990.
Gabriela Perdigon et al., “Influence of the Use of Lactobacillus Casei as an Oral Adjuvant on the Levels of Secretory Immunoglobulin A During an Infection with Salmonella Typhimurium”, Food & Agricultural Immunology (1993) 5, pp. 27-37.
H. Yasui et al.: “Immunomodulatory function of lactic acid bacteria” Antonie Van Leeuwenhoek, vol. 76, No. 1-4, pp. 383-389 Jul. 1999.
P.H. Pouwels et al.: “The potential of lactobacillus as a carrier for oral immunization” Journal of Biotechnology, vol. 44, No. 1, pp. 183-192 Jan. 26, 1996.
S. Uchida et al.: “Inhibition of animal virus plaque formation by culture filtrates of lactic acid bacteria” Kobe Journal of Medical Sciences, vol. 24, No. 2, pp. 91-98 1978.
T. Hori et al.: “Effect of intranasal administration of lactobacillus casei shirota on influenza virus infection of upper respiratory tract in mice” Clinical and Diagnostic Laboratory Immunology, vol. 8, No. 3, pp. 593-597, May 2, 2001.
G. Perdigón, et al., “Influence of the Oral Administration of Lactic Acid Bacteria on IgA Producing Cells Associated to Bronchus”, International Journal of Immunopathology and Pharmacology, Vol. 12, No. 2, 1999, pp. 97-102.
S.K. Patidar, et al., “Methods for Assessing the Immunostimulating Properties of Dietary Lactobacilli—A Critical Appraisal”, J. Food Sci. Technol., vol. 34, No. 3, 1997, pp. 181-194.
G. Perdigón, et al., “Study of the Possible Mechanisms Involved in the Mucosal Immune System Activation by Lactic Acid Bacteria”, J Dairy Sci, vol. 82, No. 6, 1999, pp. 1108-1114.
Vladimir Mihál, et al., “Protective Effect of Lactobacillus Acidophilus and Lactobacillus Casei on Encephalomyocarditis-virus-induced Disease in Mice”, Food & Agricultural Immunology, Vo. 2, 1990, pp. 205-209.
Bonavida Benjamin
Postaire Eric
Compagnie Gervais Danone
Mondesi Robert B
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Tongue Lakia J
LandOfFree
Reinforcing systemic immune responses with lactobacillus casei does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reinforcing systemic immune responses with lactobacillus casei, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reinforcing systemic immune responses with lactobacillus casei will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4096825